RxDoctor Payments Data

Eric Turney, MD

Vascular Surgery · Wooster, OHNPI 1649478041

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $8,709 of the $10,807 with a category attached, or 80.6%. It is spread thinly across 31 manufacturers, the largest accounting for just 21.0% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2023 at $2,895 and has fallen 75.2% since, to $719 in 2025.

$10,807in general payments, 2019–2025

Across 246 payments — averaging $43.93 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Bard Peripheral Vascular, Inc.$2K
  • Inari Medical, Inc.$1K
  • Medtronic$1K
  • W. L. Gore & Associates, Inc.$965
  • Abbott$867
  • Boston Scientific$830
  • plus $3K from 25 others

What the payments were for

  • Grants$170%
  • Travel & lodging$1,80417%
  • Food & beverage$8,70981%
  • Education$2783%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$10,807 in reported general payments places this provider in the 75th percentile of 213 vascular surgery providers in Ohio.

See all vascular surgery providers in Ohio

Medicare billing

Part B allowed, 2024
$99,072
Medicare patients
521
Services billed
1,022

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
ClopidogrelClopidogrel Bisulfate37$443
Cilostazol13$194
Oxycodone Hcl29$69

Paid to pharmacies, not to this prescriber.

Other vascular surgery in Wooster

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →